Calcineurin inhibitor-free GVHD prophylaxis with sirolimus and mycophenolate mofetil combination

Ann Hematol. 2017 Sep;96(9):1563-1568. doi: 10.1007/s00277-017-3062-2. Epub 2017 Jul 15.

Authors

Neeraj Saini¹, Rajneesh Nath², Jan Cerny³

Affiliations

¹ Department of Medicine, Division of Hematology/Oncology, Bone Marrow Transplant, University of Massachusetts Medical Center and Medical School, 55 Lake Avenue N, Worcester, MA, 01655, USA.
² Bone Marrow Transplant, Banner MD Anderson Cancer Center, Gilbert, AZ, USA.
³ Department of Medicine, Division of Hematology/Oncology, Bone Marrow Transplant, University of Massachusetts Medical Center and Medical School, 55 Lake Avenue N, Worcester, MA, 01655, USA. [email protected].

PMID: 28710649
DOI: 10.1007/s00277-017-3062-2

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Combined Modality Therapy
Female
Graft vs Host Disease / prevention & control*
Humans
Immunosuppressive Agents / administration & dosage
Immunosuppressive Agents / therapeutic use*
Leukemia, B-Cell / drug therapy
Leukemia, B-Cell / therapy
Leukemia, Myeloid, Acute / drug therapy
Leukemia, Myeloid, Acute / therapy
Lymphoma, Follicular / drug therapy
Lymphoma, Follicular / therapy
Male
Middle Aged
Mycophenolic Acid / administration & dosage
Mycophenolic Acid / therapeutic use*
Myelodysplastic Syndromes / drug therapy
Neoplasms, Second Primary / therapy
Peripheral Blood Stem Cell Transplantation / adverse effects
Retrospective Studies
Sirolimus / administration & dosage
Sirolimus / therapeutic use*

Substances

Immunosuppressive Agents
Mycophenolic Acid
Sirolimus